<DOC>
	<DOCNO>NCT00003863</DOCNO>
	<brief_summary>RATIONALE : Determination genetic marker aggressive non-Hodgkin 's lymphoma may help identify patient disease help predict outcome treatment . PURPOSE : Diagnostic study determine genetic marker patient aggressive non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Diagnostic Study Patients With Aggressive Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Estimate proportion patient diffuse aggressive non-Hodgkin 's lymphoma rearrangement affect MYC , BCL2 , BCL6 gene ( determine fluorescent situ hybridization ) , overtly amplify chromosomal region , nonrandom copy number change chromosomal region ( determine comparative genomic hybridization ) . - Investigate prognostic importance genetic marker study relationship clinical outcome ( e.g. , response therapy , failure-free survival , overall survival ) patient . - Investigate interrelationship among genetic biological marker relationships clinical feature disease , disease site ( nodal v extranodal ) stage , patient . OUTLINE : This multicenter study . Tissue sample obtain treatment time documentation refractory disease patient achieve complete remission induction therapy time first relapse patient achieve complete remission . Samples examine rearrangement MYC , BCL2 , BCL6 , IGH gene use fluorescent situ hybridization . DNA examine comparative genomic hybridization , allow cytogenetic detection loss gain chromosomal region tumor cell . Patients receive result genetic test result influence type duration treatment .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven aggressive nonHodgkin 's lymphoma register frontline CALGB protocol ( e.g , CLB59903 , 59909 , 10002 , 50103 ) Diffuse small cleave cell lymphoma Diffuse mix small large cell lymphoma Diffuse large cell lymphoma Diffuse large cell immunoblastic lymphoma Small noncleaved cell lymphoma Mantle cell lymphoma OR Previously enter similar curative CALGB protocol ( CLB8852 , CLB8854 , CLB9351 ) block unstained slide initial diagnosis available PATIENT CHARACTERISTICS : Age : 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage I adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage I mantle cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>contiguous stage II mantle cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
</DOC>